ImportRefusal LogoImportRefusal

PCI Pharma Services Canada, Inc.

⚠️ Moderate Risk

FEI: 3007309095 • Mississauga, Ontario • CANADA

FEI

FEI Number

3007309095

📍

Location

Mississauga, Ontario

🇨🇦

Country

CANADA
🏢

Address

1 Rimini Mews, , Mississauga, Ontario, Canada

Moderate Risk

FDA Import Risk Assessment

43.3
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

2
Total Refusals
1
Unique Violations
11/20/2006
Latest Refusal
10/17/2006
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
17.7×30%
Recency
0.0×20%
Frequency
20.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
11/20/2006
65AIB99MEMORY ADJUVANT, N.E.C.
75UNAPPROVED
New Orleans District Office (NOL-DO)
10/17/2006
64UIE99INHIBITOR N.E.C.
75UNAPPROVED
New York District Office (NYK-DO)

Frequently Asked Questions

What is PCI Pharma Services Canada, Inc.'s FDA import refusal history?

PCI Pharma Services Canada, Inc. (FEI: 3007309095) has 2 FDA import refusal record(s) in our database, spanning from 10/17/2006 to 11/20/2006.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. PCI Pharma Services Canada, Inc.'s FEI number is 3007309095.

What types of violations has PCI Pharma Services Canada, Inc. received?

PCI Pharma Services Canada, Inc. has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about PCI Pharma Services Canada, Inc. come from?

All FDA import refusal data for PCI Pharma Services Canada, Inc. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.